Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pancreatin Supplement Therapy in Critically Ill Adults
ChiCTR2100052385Phase 4Not yet recruiting
- Sponsor
- Shanghai Tenth People's Hospital
- Start
- Nov 2021
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes, Blood Coagulation Factors → Therapeutic Enzymes → Recombinant Proteins and Enzymes, Insulin and Analogs → Hormones & Growth Factors → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of pancreatin in critical illness and exocrine pancreatic insufficiency (EPI) (2 arms), sponsored by Shanghai Tenth People's Hospital. Primary endpoint: Rectus femoris cross-sectional area. Planned start Nov 2021; status: not yet recruiting.
02
Drugs
pancreatin
03
Conditions
critical illnessexocrine pancreatic insufficiency (EPI)
Beyond the preview
Go deeper on ChiCTR2100052385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100052385.